Biotricity, Inc. (BTCY) financial statements (2022 and earlier)

Company profile

Business Address 275 SHORELINE DRIVE
REDWOOD CITY, CA 94065
State of Incorp. NV
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
12/31/2016
8/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,7902,20295064844214
Cash and cash equivalents16,7902,20295064844214
Receivables1,9891,521486208 434
Inventory, net of allowances, customer advances and progress billings3602728625   
Inventory3602728625   
Deposits current assets47132713710117  
Other undisclosed current assets   603610(19)
Total current assets:19,6104,3221,6594588963519
Noncurrent Assets
Operating lease, right-of-use asset1,37166264
Property, plant and equipment29      
Long-term investments and receivables3      
Accounts and financing receivable, after allowance for credit loss3      
Deposits noncurrent assets33 333333  
Other undisclosed noncurrent assets 5048  33 
Total noncurrent assets:1,436116346333333 
TOTAL ASSETS:21,0454,4382,0044919296819
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,9172,5201,5221,4017561,161181
Accounts payable1,4291,0411,094878548824181
Accrued liabilities1,4881,479428522208337 
Other undisclosed accounts payable and accrued liabilities0      
Debt1,1384,2782,068    
Deferred compensation liability      48
Derivative instruments and hedges, liabilities5723,634     
Other undisclosed current liabilities20258213    
Total current liabilities:4,82910,4903,8031,4017561,161229
Noncurrent Liabilities
Long-term debt and lease obligation13,611 57    
Long-term debt, excluding current maturities12,434      
Operating lease, liability1,177 57
Liabilities, other than long-term debt2874101,145    
Derivative instruments and hedges, liabilities2874101,145    
Other undisclosed noncurrent liabilities 371     
Total noncurrent liabilities:13,8987811,202    
Other undisclosed liabilities   868 2,97534
Total liabilities:18,72611,2715,0052,2687564,136262
Stockholders' equity
Stockholders' equity attributable to parent, including:2,319(6,833)(3,000)(1,778)173(4,069)(244)
Preferred stock0 0000 
Common stock5039363532269
Additional paid in capital85,87456,29944,01533,89027,16212,47913
Accumulated other comprehensive loss(636)(634)(857)(755)(643)(265) 
Accumulated deficit(87,055)(62,818)(46,364)(35,039)(26,447)(16,510) 
Other undisclosed stockholders' equity attributable to parent4,0862811699170201(266)
Total stockholders' equity:2,319(6,833)(3,000)(1,778)173(4,069)(244)
TOTAL LIABILITIES AND EQUITY:21,0454,4382,0044919296819

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
12/31/2016
8/31/2015
Revenues7,8313,3851,418398   
Cost of revenue(3,847)(1,871)(725)(249)  (35)
Cost of goods and services sold      (35)
Gross profit:3,9841,514692150  (35)
Operating expenses(23,798)(14,865)(11,623)(8,742)(7,724)(4,973)(52)
Other operating expense, net
(Other Expenses)
      (1)
Operating loss:(19,814)(13,352)(10,931)(8,592)(7,724)(4,973)(87)
Nonoperating income (expense)1,101(37)  (230)  
Foreign currency transaction loss, before tax    (230)  
Other nonoperating income (expense)1,101(37)     
Interest and debt expense(38)1,200     
Other undisclosed income from continuing operations before equity method investments, income taxes1,163      
Loss from continuing operations before equity method investments, income taxes:(17,588)(12,188)(10,931)(8,592)(7,953)(4,973)(87)
Other undisclosed loss from continuing operations before income taxes(14,953)(3,303)(136)    
Loss from continuing operations:(32,541)(15,491)(11,067)(8,592)(7,953)(4,973)(87)
Loss from discontinued operations      (91)
Loss before gain (loss) on sale of properties:(32,541)(15,491)(11,067)(8,592)(7,953)(4,973)(178)
Other undisclosed net income (loss)    (670) 87
Net loss:(32,541)(15,491)(11,067)(8,592)(8,624)(4,973)(91)
Other undisclosed net loss attributable to parent(0)    (2,308) 
Net loss attributable to parent:(32,541)(15,491)(11,067)(8,592)(8,624)(7,281)(91)
Preferred stock dividends and other adjustments(1,658)(962)(258)    
Other undisclosed net income available to common stockholders, basic0 0    
Net loss available to common stockholders, diluted:(34,199)(16,453)(11,325)(8,592)(8,624)(7,281)(91)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
12/31/2016
8/31/2015
Net loss:(32,541)(15,491)(11,067)(8,592)(8,624)(4,973)(91)
Other comprehensive loss    (8,624)(7,281) 
Comprehensive loss:(32,541)(15,491)(11,067)(8,592)(17,247)(12,253)(91)
Other undisclosed comprehensive loss, net of tax, attributable to parent(147,263)(146,839)(360)(112)   
Comprehensive loss, net of tax, attributable to parent:(179,804)(162,330)(11,427)(8,704)(17,247)(12,253)(91)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: